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Summary 
 
Three experiments were conducted to de-
termine effects of ractopamine-HCl, sold un-
der the trade name Optaflexx, on rumen fer-
mentation.  In experiment 1, fermentative gas 
production was measured in vitro to determine 
the impact of increasing amounts of ractopa-
mine-HCl added to rumen fluid.  Ractopa-
mine-HCl increased gas production when 
added to rumen fluid up to 10 times the as-
sumed physiological dosage of 200 mg per 
head/day, but depressed gas production at 100 
times the physiological dose. Experiment 2 
and 3 evaluated the effects of ractopamine-
HCl on production of volatile fatty acids 
(VFAs) by ruminal microbes. In vitro experi-
ments revealed no effect of ractopamine on 
volatile fatty acid production, but VFA levels 
in rumen fluid of cattle 23 hours after feeding 
were lower for cattle fed Optaflexx then for 
controls (P = 0.01).  Results of these studies 
indicate that ractopamine-HCl has a direct in-
fluence on fermentation by rumen microflora.   
 
Introduction 
 
Ractopamine-HCl is a beta-agonist similar 
in structure to catecholamines and is marketed 
commercially under the trade name Optaflexx.  
Feeding Optaflexx accelerates gain and im-
proves efficiency when administered to cattle 
during the final 4 to 6 weeks of feedlot finish-
ing.  Naturally occurring catecholamines have 
been noted to affect certain types of microor-
ganisms. Consequently, researchers were in-
terested in determining if ractopamine-HCl 
could impact ruminal microorganisms in a 
similar manner.  
 
Materials and Methods 
 
Experiment 1.  Concentrations of racto-
pamine-HCl were 0, 0.0339, 0.3339, 3.339, or 
33.39 mg RAC per gram of corn dry matter 
were compared in an in vitro experiment with 
rumen microorganisms. Ground corn was 
added to each flask as a source of substrate for 
the microorganisms.  Rumen fluid was mixed 
with McDougall’s artificial saliva to a final 
ratio of 2:1 and added to the culture flasks.  
Flasks were incubated at body temperature, 
and gas production was measured at hourly 
intervals for 6 hours.   
 
Experiment 2.  In vitro VFA profiles 
were determined with five concentrations of 
ractopamine-HCl (0, 0.0339, 0.3339, 3.339, or 
33.39 mg RAC per gram of corn dry matter) 
added to flasks.  Flasks were incubated 6 
hours, and VFA concentrations were deter-
mined using gas chromatography. 
 
Experiment 3.  Rumen fluid samples used 
to determine in vivo VFA profiles were ob-
tained from 60 cross-bred heifers fed a 94% 
concentrate ration formulated to provide 0 or 
200 mg/day Optaflexx.  Samples were taken 
23 hours after feeding.  Heifers were sampled 
on two separate occasions.  Samples were ana-
lyzed for VFA concentrations.  
 
         
 
1Optaflexx is a registered trademark of Elanco Animal Health, Indianapolis, IN. 
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Results and Discussion 
 
Experiment 1.  Optaflexx concentration 
had a quadratic effect on in vitro gas produc-
tion.  Gas production increased significantly 
from the control with addition of Optaflexx at 
the concentration of .3339 mg of RAC per 
gram of corn dry matter and 3.339 mg RAC 
per gram of corn dry matter (P<0.05).  The 
highest concentration resulted in the lowest 
gas production. The increase in gas production 
in response to increased concentration of rac-
topamine-HCl provides evidence that changes 
are occurring in the rumen of cattle fed Op-
taflexx.  The decline in gas production at 
33.39 mg RAC per gram of corn dry matter 
indicates that the rumen can be exhausted by 
an excessive amount of ractopamine-HCl, 
negatively impacting the rumen microflora.   
 
Experiment 2 and 3.  The VFA profiles 
from in vitro fermentations are not different 
among increasing levels of Optaflexx (Table 
1). Optaflexx decreased total VFA production 
in vivo (P = 0.014, Table 2).  The contradic-
tion between in vitro and in vivo VFA profiles 
may be a result of the sampling technique.  
The in vitro samples were obtained sis hours 
after the substrate was added to the batch fer-
mentation system.  Heifers were sampled 23 
hours after feeding for the in vivo analysis. 
The decline in total VFA production may be a 
result of more extensive digestion of the ration 
rather than from a decline in VFA production.  
Sampling rumen fluid from cattle ruminally 
cannulated at several time points after feeding 
of Optaflexx may better illustrate the effects 
on fermentation and the rumen.     
 
Conclusion/ Implication 
 
Supplementing cattle with Optaflexx 
changes the rumen environment.  Developing 
a greater understanding of these changes may 
make it possible to further improve responses 
to Optaflexx supplementation.   
 
 
 
Table 1.  Effects of Ractopamine-HCl on In Vitro VFA Profiles 
 Volatile Fatty Acid Concentration, mM 
 Acetate Propionate Butyrate Isobutyrate Isovalerate Valerate Total 
Control 28.41 13.21 7.07 0.63 1.62 1.04 51.96
Ractopamine-HCL 28.85 13.12 7.49 0.65 1.68 1.08 52.86
Control and ractopamine are not different, P>0.50 
 
 
Table 2.  Effects of Optaflexx Supplementation on In Vivo VFA Profiles 
 Volatile Fatty Acid Concentration, mM 
 Acetatea Propionatea Butyrateb Isobutyrateb Isovalerate Valeratea Totala 
Control 27.65 31.08 6.48 0.34 0.65 2.48 68.62 
Optaflexx 25.33 28.37 5.7 0.37 0.68 2.08 62.52 
aControl and Optaflexx groups are different, P<0.05. 
bControl and Optaflexx groups are different, P<0.10. 
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Figure 1.  The Amount of Fermentative Gas Produced by Rumen Microbes During a 6 
Hour In Vitro Fermentation with 5 Concentrations of Ractopamine-HCl.  Gas production 
was measured as ml of water displaced during the six hour fermentation.  a,b,c,dMeans without a 
common superscript are different (P<0.10).  
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